Skip to main content
. 2023 Sep 13;12(9):1760. doi: 10.3390/antiox12091760

Table 1.

Examples of natural antioxidants candidates for improving clinical outcomes in patients undergoing MIRI and/or cerebral IRI.

Antioxidant Family Antioxidant Formula Prevention Proposed Target
Polyphenols Resveratrol graphic file with name antioxidants-12-01760-i001.jpg MIRI [60] and CIRI [61] Ameliorate OS by increase in Nrf2 expression [61,62]. Also, decrease inflammation through TLR4/NF-κB signaling pathway [61,63].
Quercetin graphic file with name antioxidants-12-01760-i002.jpg MIRI [64] and
CIRI [65,66]
Scavenging and inhibition of ROS, and induction of Nrf2/HO-1 expression [65].
Curcumin graphic file with name antioxidants-12-01760-i003.jpg MIRI [67] and CIRI [68] Decrease myocardial apoptosis by activating JAK2/STAT3 pathway, thus reducing OS-damage [67]; while neuroprotection could be due to inhibition of pyroptosis by suppressing the p38 MAPK pathway [69].
Carotenoids Lycopene graphic file with name antioxidants-12-01760-i004.jpg MIRI [33] and CIRI [70] Inhibit mPTP opening via modulation of Bax and Bcl-2 [33,70].
Crocin graphic file with name antioxidants-12-01760-i005.jpg MIRI [71] and CIRI [58] In the heart, there is a regulation of SIRT1/Nrf2 signaling and related endoplasmic reticulum stress [71], while in the brain, a reduction in HIF-1α and caspase-3 was seen [58].
β-carotene graphic file with name antioxidants-12-01760-i006.jpg MIRI [72] and CIRI [73] Inhibit NF-κB pathway [73].
Astaxanthin graphic file with name antioxidants-12-01760-i007.jpg MIRI [74] and CIRI [75] Activate Nrf2/HO-1 pathway, regulate the miR-138/HIF-1α axis [74]. Enhance the expressions of SOD1 and 2 [75]
Lutein graphic file with name antioxidants-12-01760-i008.jpg CIRI [76] Decrease SOD, CAT and GTX activity [76].
Vitamins All-trans retinoic acid (ATRA) graphic file with name antioxidants-12-01760-i009.jpg MIRI [77] and CIRI [78] Downregulation of MAPK signaling [77,78].
Vitamin C graphic file with name antioxidants-12-01760-i010.jpg MIRI [79] and
CIRI [80]
Decrease SOD activity [81] and PI3K-Akt signaling pathway [79].
Vitamin D (α-tocopherol) graphic file with name antioxidants-12-01760-i011.jpg MIRI [82] and CIRI [83] Reduce inflammation RhoA/ROCK/NF-ĸB pathway [82], activate Nrf2/HO-1 pathway, and suppress NLRP3-mediated pyroptotic pathway [83].
Vitamin E graphic file with name antioxidants-12-01760-i012.jpg MIRI [84] and CIRI [85] Downregulation of GPX (1, 5 and 6) and MPO [84].
Folic acid graphic file with name antioxidants-12-01760-i013.jpg CIRI [86] Inhibition of NMDAR [86].
Others Ginsenoside Rg1 graphic file with name antioxidants-12-01760-i014.jpg CIRI [87] Activation of Nrf2/ARE pathway [88].
Ginsenoside Rb1 graphic file with name antioxidants-12-01760-i015.jpg MIRI [89,90] Reduce succinate-driven ROS production by inhibiting NADH dehydrogenase in mitochondrial complex I [91].

Akt: protein kinase B; ARE: antioxidant response elements; CIRI: cerebral ischemia–reperfusion injury; GPX: glutathione peroxidase; HO-1: heme oxygenase-1; MIRI: myocardial ischemia–reperfusion injury; MPO: myeloperoxidase; mPTP: mitochondrial permeability transition pore; NF-κB: nuclear factor kappa B; NMDAR: N-methyl-D-aspartate receptor; Nrf2: Nuclear factor erythroid 2-related factor 2; PI3K: phosphoinositide 3-kinase; ROS: reactive oxygen species; SIRT1: sirtuin 1; SOD: superoxide dismutase; TLR4: Toll-like receptor 4.